PFBT
AUPH icon

Parkside Financial Bank & Trust’s Aurinia Pharmaceuticals AUPH Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78K Hold
120
– – ﹤0.01% 2157
2025
Q4 		$1.91K Hold
120
– – ﹤0.01% 2114
2025
Q3 		$1.33K Hold
120
– – ﹤0.01% 2168
2025
Q2 		$1.02K Buy
+120
New +$962 ﹤0.01% 2265

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Parkside Financial Bank & Trust's AUPH Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Aurinia Pharmaceuticals (AUPH) position steady in Q1 2026 at 120 shares worth $1.78K. The position accounts for ﹤0.01% of the portfolio, ranked #2157.

Parkside Financial Bank & Trust first reported a position in AUPH in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.91K in Q4 2025. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Parkside Financial Bank & Trust held 120 shares of Aurinia Pharmaceuticals worth $1.78K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Aurinia Pharmaceuticals share count unchanged in Q1 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2157 holding.
  • Parkside Financial Bank & Trust first reported a position in Aurinia Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's Aurinia Pharmaceuticals position peaked at $1.91K in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.